Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S. M.R.C.P (UK), M.C.C.E.E (Canada), F.C.P.S (Medicine)
Internal Medicine Specialist
M.B.B.S. M.R.C.P (UK), M.C.C.E.E (Canada), F.C.P.S (Medicine)
General Physician
MBBS, F.C.P.S.
General Physician
M.B.B.S., Certified Diabetologist , Certified Hypertension Specialist
General Physician
M.B.B.S., Certified Diabetologist , Certified Hypertension Specialist
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, MD (Internal Medicine)
Gastroenterologist
M.B.B.S, F.C.P.S. (Gastroenterology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P (UK)
General Physician
MBBS, FCPS
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures